Lv1
20 积分 2022-06-15 加入
Leptomeningeal metastases in non-small cell lung cancer: Diagnosis and treatment
13天前
已完结
Evolving management of HER2+ breast cancer brain metastases and leptomeningeal disease
13天前
已完结
Chapter 13 - Leptomeningeal metastasis
13天前
已关闭
Leptomeningeal carcinomatosis in non-small cell lung cancer patients: A continuing challenge in the personalized treatment era
14天前
已完结
Survival and prognostic factors of HER2-mutant advanced non-small cell lung cancer with brain metastases
14天前
已完结
PL04.07 FURTHER: A Global, Randomized Study of Firmonertinib at Two Dose Levels in TKI-Naive, Advanced NSCLC with EGFR PACC Mutations
1个月前
已完结
Management of HER2 alterations in non-small cell lung cancer – The past, present, and future
2个月前
已完结
BAY 2927088: The first non-covalent, potent, and selective tyrosine kinase inhibitor targeting EGFR exon 20 insertions and C797S resistance mutations in NSCLC
2个月前
已完结
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
3个月前
已完结
Dual αV-integrin and neuropilin-1 targeting peptide CEND-1 plus nab-paclitaxel and gemcitabine for the treatment of metastatic pancreatic ductal adenocarcinoma: a first-in-human, open-label, multicentre, phase 1 study
3个月前
已完结
皖公网安备34019202002308
